Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 No end in sight for telomerase-targeted cancer drugs.

× No keyword cloud information.

15 in total

Review 1. Telomere biology: Rationale for diagnostics and therapeutics in cancer.

Authors: Philippe Rousseau; Chantal Autexier
Journal: RNA Biol Date: 2015-08-20 Impact factor: 4.652

2. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.

Authors: Ozlem Kulak; Hua Chen; Brody Holohan; Xiaofeng Wu; Huawei He; Dominika Borek; Zbyszek Otwinowski; Kiyoshi Yamaguchi; Lauren A Garofalo; Zhiqiang Ma; Woodring Wright; Chuo Chen; Jerry W Shay; Xuewu Zhang; Lawrence Lum
Journal: Mol Cell Biol Date: 2015-05-04 Impact factor: 4.272

3. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.

Authors: Yafang Hu; Daniel Bobb; Jianping He; D Ashley Hill; Jeffrey S Dome
Journal: Cancer Biol Ther Date: 2015-04-28 Impact factor: 4.742

4. Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms.

Authors: Jenny Dahlström; Xiaolu Zhang; Mehran Ghaderi; Malin Hultcrantz; Magnus Björkholm; Dawei Xu
Journal: Haematologica Date: 2015-07-16 Impact factor: 9.941

5. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.

Authors: Ilgen Mender; Sergei Gryaznov; Z Gunnur Dikmen; Woodring E Wright; Jerry W Shay
Journal: Cancer Discov Date: 2014-12-16 Impact factor: 39.397

Review 6. Telomeres and telomerase in prostate cancer development and therapy.

Authors: Mindy Kim Graham; Alan Meeker
Journal: Nat Rev Urol Date: 2017-07-04 Impact factor: 14.432

7. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.

Authors: Xinsen Xu; Wei Chen; Runchen Miao; Yanyan Zhou; Zhixin Wang; Lingqiang Zhang; Yong Wan; Yafeng Dong; Kai Qu; Chang Liu
Journal: Oncotarget Date: 2015-02-28

8. A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).

Authors: Patrick A Thompson; Rachid Drissi; Jodi A Muscal; Eshini Panditharatna; Maryam Fouladi; Ashish M Ingle; Charlotte H Ahern; Joel M Reid; Tong Lin; Brenda J Weigel; Susan M Blaney
Journal: Clin Cancer Res Date: 2013-10-04 Impact factor: 12.531

Review 9. Risk factors and therapeutic targets in pancreatic cancer.

Authors: Sonja Maria Wörmann; Hana Algül
Journal: Front Oncol Date: 2013-11-18 Impact factor: 6.244

Review 10. Telomere maintenance mechanisms in cancer: clinical implications.

Authors: Roger R Reddel
Journal: Curr Pharm Des Date: 2014 Impact factor: 3.116